Naproxen is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Apotheca Inc.. The primary component is Naproxen.
| Product ID | 12634-498_35b8ec82-7260-5925-e054-00144ff8d46c | 
| NDC | 12634-498 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | Naproxen | 
| Generic Name | Naproxen | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2010-02-18 | 
| Marketing Category | ANDA / ANDA | 
| Application Number | ANDA075927 | 
| Labeler Name | Apotheca Inc. | 
| Substance Name | NAPROXEN | 
| Active Ingredient Strength | 250 mg/1 | 
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2019-12-31 | 
| Marketing Start Date | 2010-02-18 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Marketing Category | ANDA | 
| Application Number | ANDA075927 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Marketing Start Date | 2010-02-18 | 
| Inactivation Date | 2020-01-31 | 
| Ingredient | Strength | 
|---|---|
| NAPROXEN | 250 mg/1 | 
| SPL SET ID: | 35b8ec82-725f-5925-e054-00144ff8d46c | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| PHarm Class EPC | |
| NUI Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0054-3630 | Naproxen | Naproxen | 
| 0093-1005 | Naproxen | Naproxen | 
| 0093-1006 | Naproxen | Naproxen | 
| 0143-1346 | Naproxen | Naproxen | 
| 0143-1347 | Naproxen | Naproxen | 
| 0143-1348 | Naproxen | Naproxen | 
| 0143-9908 | NAPROXEN | naproxen sodium | 
| 0143-9916 | NAPROXEN | naproxen sodium | 
| 0179-1978 | Naproxen | Naproxen | 
| 0440-1852 | Naproxen | Naproxen | 
| 0440-7852 | Naproxen | Naproxen | 
| 0615-1504 | Naproxen | Naproxen | 
| 0615-3562 | Naproxen | Naproxen | 
| 0615-3563 | Naproxen | Naproxen | 
| 0615-7709 | Naproxen | Naproxen | 
| 0615-7892 | Naproxen | Naproxen | 
| 0615-8094 | Naproxen | Naproxen | 
| 10544-010 | Naproxen | Naproxen | 
| 10544-016 | Naproxen | Naproxen | 
| 10544-019 | Naproxen | Naproxen | 
| 10544-044 | Naproxen | Naproxen | 
| 10544-061 | Naproxen | Naproxen | 
| 10544-111 | NAPROXEN | NAPROXEN | 
| 10544-277 | Naproxen | Naproxen | 
| 10544-278 | Naproxen | Naproxen | 
| 10544-614 | NAPROXEN | naproxen sodium | 
| 10544-920 | Naproxen | Naproxen | 
| 10544-922 | Naproxen | Naproxen | 
| 10544-939 | Naproxen | Naproxen | 
| 12634-498 | Naproxen | Naproxen | 
| 68071-3092 | Naproxen | Naproxen | 
| 68071-4006 | NAPROXEN | NAPROXEN | 
| 68071-3029 | naproxen | naproxen | 
| 68071-3066 | naproxen | naproxen | 
| 68071-3387 | Naproxen | Naproxen | 
| 68071-3345 | NAPROXEN | NAPROXEN | 
| 68071-4510 | NAPROXEN | NAPROXEN | 
| 68071-4381 | NAPROXEN | NAPROXEN | 
| 68134-201 | Naproxen | Naproxen | 
| 68151-2894 | Naproxen | Naproxen | 
| 68151-2609 | Naproxen | Naproxen | 
| 68151-2895 | Naproxen | Naproxen | 
| 68382-012 | Naproxen | Naproxen | 
| 68382-013 | Naproxen | Naproxen | 
| 68382-014 | Naproxen | Naproxen | 
| 68387-800 | Naproxen | Naproxen | 
| 68387-801 | Naproxen | Naproxen | 
| 68387-802 | Naproxen | Naproxen | 
| 68462-190 | Naproxen | Naproxen | 
| 68462-189 | Naproxen | Naproxen |